John M. Wesolowski

CIK: 0001895944

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INTS

INTENSITY THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

INTS
INTENSITY THERAPEUTICS, INC.
Jul 16, 2026
Award(A)
Stock Option (right to buy Common Stock)
Direct
11K shares-
INTS
INTENSITY THERAPEUTICS, INC.
Jun 30, 2026
Award(A)
Direct
3.7K shares at avg. $3.48$13K
INTS
INTENSITY THERAPEUTICS, INC.
Dec 31, 2025
Award(A)
Direct
8.9K shares at avg. $0.26$2K
INTS
INTENSITY THERAPEUTICS, INC.
Jun 30, 2025
Award(A)
Direct
69.7K shares at avg. $0.26$18K
INTS
INTENSITY THERAPEUTICS, INC.
May 2, 2025
Award(A)
Stock Option (right to buy Common Stock)
Direct
100K shares-
INTS
INTENSITY THERAPEUTICS, INC.
May 2, 2025
Award(A)
Stock Option (right to buy Common Stock)
Direct
100K shares-
INTS
INTENSITY THERAPEUTICS, INC.
Oct 21, 2024
Award(A)
Stock Option (right to buy Common Stock)
Direct
70K shares-

		Type	Shares	Price		Ownership
Jul 16, 2026	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	11,000	-	-	Direct
Jun 30, 2026	INTS INTENSITY THERAPEUTICS, INC.	Award(A)	3,688	$3.48	$12,853	Direct
Dec 31, 2025	INTS INTENSITY THERAPEUTICS, INC.	Award(A)	8,918	$0.26	$2,337	Direct
Jun 30, 2025	INTS INTENSITY THERAPEUTICS, INC.	Award(A)	69,745	$0.26	$18,203	Direct
May 2, 2025	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	100,000	-	-	Direct
May 2, 2025	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	100,000	-	-	Direct
Oct 21, 2024	INTS INTENSITY THERAPEUTICS, INC.	Award(A) Stock Option (right to buy Common Stock)	70,028	-	-	Direct

1-7 of 7 transactions

About Wesolowski John M

Wesolowski John M (SEC CIK 0001895944) files insider reports with the SEC as Principal Accounting Officer of INTENSITY THERAPEUTICS, INC. (INTS).

Signal8 holds 7 ownership filings by Wesolowski John M, all Form 4s, filed between Oct 23, 2024 and Jul 20, 2026. Those filings report 7 transactions, from Oct 21, 2024 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wesolowski John M's filings is in SHELTON, CT.

Recent filings by Wesolowski John M

Jul 16, 2026: Grant or award of INTS derivative securities (Form 4, code A).
Jun 30, 2026: Grant or award of INTS shares (Form 4, code A).
Dec 31, 2025: Grant or award of INTS shares (Form 4, code A).
Jun 30, 2025: Grant or award of INTS shares (Form 4, code A).
May 2, 2025: Grants or awards of INTS derivative securities (2 lines, Form 4, code A).

Other insiders filing for INTENSITY THERAPEUTICS, INC. (INTS)

DUBIN THOMAS I H, Director
Donovan Daniel, Director
GOLDBERG MARK A, Director
Leahy Emer, Director
Talamo Joseph, Chief Financial Officer
BENDER LEWIS H, President and CEO

How to read Form 4 transaction codes